Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuwa Ando
Observed names:
Ando, Yuwa,
安藤, 雄和
Institutions:
St. Marianna University School of Medicine,
Institute of Science Tokyo,
Laboratory for Future Interdisciplinary Research of Science and Technology
Observed institutions:
Hiroshima University,
St. Marianna University School of Medicine,
Hiroshima University Hospital,
Institute of Science Tokyo,
Laboratory for Future Interdisciplinary Research of Science and Technology,
Research Institute for Radiation Biology and Medicine, Hiroshima University
show all 6
ORCID:
0009-0007-2603-7054
Observed ORCID:
0009-0007-2603-7054
OpenAlex ID:
A5104025623
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma
2021
·
Yuwa Ando
, Tomokazu Kawaoka
, et al.
·
Oncology
·
58
Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice
2021
·
Yuwa Ando
, Tomokazu Kawaoka
, et al.
·
Cancers
·
45
PDF
Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal Vein
2021
·
Yumi Kosaka
, Tomoki Kimura
, et al.
·
Liver Cancer
·
44
Incidence of microsatellite instability‐high hepatocellular carcinoma among Japanese patients and response to pembrolizumab
2020
·
Tomokazu Kawaoka
, Yuwa Ando
, et al.
·
Hepatology Research
·
42
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study
2021
·
Yuko Nagaoki
, Hideyuki Hyogo
, et al.
·
BMC Gastroenterology
·
36
PDF
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib
2020
·
Yuwa Ando
, Tomokazu Kawaoka
, et al.
·
Oncology
·
31
Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
2022
·
Yuwa Ando
, Tomokazu Kawaoka
, et al.
·
Liver Cancer
·
20
PDF
Complete response to pembrolizumab in advanced hepatocellular carcinoma with microsatellite instability
2020
·
Yuwa Ando
, Masami Yamauchi
, et al.
·
Clinical Journal of Gastroenterology
·
20
Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein
2023
·
Takahiro Kinami
, Kei Amioka
, et al.
·
Cancers
·
15
PDF
Trends in Hepatic Functional Reserve of Patients with Hepatocellular Carcinoma Treated with Tyrosine Kinase Inhibitors
2020
·
Shinsuke Uchikawa
, Tomokazu Kawaoka
, et al.
·
Oncology
·
14
Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma
2022
·
Kei Amioka
, Tomokazu Kawaoka
, et al.
·
Cancers
·
12
PDF
The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment
2022
·
Kenji Yamaoka
, Kenichiro Kodama
, et al.
·
PLoS ONE
·
11
PDF
Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
2021
·
Shigeki Yano
, Tomokazu Kawaoka
, et al.
·
Medicine
·
11
Sodium-glucose cotransporter-2 inhibitors improve FibroScan-aspartate aminotransferase scores in patients with nonalcoholic fatty liver disease complicated by type 2 diabetes
2023
·
Yutaro Ogawa
, Takashi Nakahara
, et al.
·
European Journal of Gastroenterology & Hepatology
·
10
Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma
2020
·
Kenji Yamaoka
, Kenichiro Kodama
, et al.
·
Journal of Gastroenterology and Hepatology
·
10
Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab
2023
·
Chihiro Kikugawa
, Shinsuke Uchikawa
, et al.
·
Oncology
·
8
The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib
2023
·
Kikugawa Chihiro
, Tomokazu Kawaoka
, et al.
·
Oncology
·
7
Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma—Consideration of the Locations of Target Lesions
2023
·
Shigeki Yano
, Tomoki Kimura
, et al.
·
Cancers
·
7
PDF
Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma
2022
·
Kei Amioka
, Tomokazu Kawaoka
, et al.
·
Cancers
·
7
PDF
Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection
2022
·
Kenichiro Kodama
, Tomokazu Kawaoka
, et al.
·
Journal of Gastroenterology
·
6
Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma
2021
·
Kensuke Naruto
, Tomokazu Kawaoka
, et al.
·
Oncology
·
6
Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy
2021
·
Kei Amioka
, Tomokazu Kawaoka
, et al.
·
Oncology
·
6
A case of advanced HCC treated with lenvatinib after hepatic arterial infusion chemotherapy combined with radiation therapy treatment for portal vein tumor thrombosis in the main trunk
2020
·
Yumi Kosaka
, Tomokazu Kawaoka
, et al.
·
Clinical Journal of Gastroenterology
·
6
Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varices
2022
·
Yuki Shirane
, Eisuke Murakami
, et al.
·
BMC Gastroenterology
·
5
PDF
Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort study
2022
·
Kensuke Naruto
, Tomokazu Kawaoka
, et al.
·
BMC Gastroenterology
·
4
PDF
Show more works
View as search
Works count:
93
Citation count:
455
H-index:
11
I10-index:
15
Year
Topic
Type